Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Retrospective and Prospective Disease Progression and Quality of Life in X-linked Hypophosphatemia (XLH)

NCT04049877 is registered in ClinicalTrials.gov with Medialis Ltd. as lead sponsor.

NCT NCT04049877
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04049877 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Retrospective and Prospective Disease Progression and Quality of Life in X-linked Hypophosphatemia (XLH)
Lead sponsor
Medialis Ltd.
Phase
Observational
Overall status
Completed
Start date
July 7, 2019
Completion date
July 28, 2021
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

x-linked hypophosphatemia (xlh)